loader2
Partner With Us NRI

Company details

95.25
98.80
84.60
156.00
6M Return -8.14%
1Y Return -36.02%
Mkt Cap.(Cr) 486.09
Volume 7,294
Div Yield 1.77%
OI
-
OI Chg %
-
Volume 7,294

Open Free Demat Account Online with ICICIDIRECT

SWOT

  • swot

  • technicals

  • deals

  • shareholding


EMA SMA

Delivery and volume

Financials

  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio

Sales(Cr.)

Operating Profit(Cr.)

Profit after Tax(Cr.)

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after tax

PE

Debt/Equity

P BV

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 190.65 Cr FV: 5.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 28,019.57 -43,282.61
LAST 3M 77,901.94 -49,701.23
LAST 6M 142,324.16 -198,923.20
LAST 12M 202,461.29 -168,761.49

Information

  • About Company
  • Company Info
  • Listing Info
16.21
70.43%
42.6596
15.72%
12.75%
Description
  • Anuh Pharma Ltd is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs). The company offers bulk drugs and chemicals. Their products are antibiotics, erythromycin salts, chloramphenicol and other chemicals. The company is part of the SK Group. Anuh Pharma Ltd was incorporated on February 19, 1960. The company is well positioned to service their existing and potential markets through their manufacturing operations at Tarapur in Maharashtra. All the facilities are built and operated according to cGMP. They also received plant approvals from several MNCs. The business headquarters of the firm is located in the commercial capital of India, Mumbai. The company is a recognized export house and exports their products to Mexico, Brazil, Iran, Bangladesh, Colombia, Germany, Africa, Singapore and several other countries. During the year 2006-07, the company commissioned the new plant with all latest modern techniques and facilities. Thus, the production capacity of Antibiotics increased from 400,000 Kg to 600,000 Kg. During the year 2008-09, the company completed the on-going expansion of their plant, thus they increased the installed capacity by 150 MT per annum. In September 2008, they expanded unit started commercial production. In January 2010, the company received approval for their product Erythromycin E.P. from European Directorate for the Quality of Medicines & HealthCare (EDQM). This approval paves the way for the company to sell Erythromycin E.P. in European counties for their own consumption. In April 2010, the company received approval for their product Pyrazinamide from European Directorate for the Quality of Medicines & HealthCare (EDQM). This approval paves the way for the company to sell Pyrazinamide in European countries for their own consumption. In June 2010, the company received approval for their product Clobetasol Propionate from European Directorate for the Quality Medicines & Healthcare. This approval paves the way for the company to sell Clobetasol Propionate in European counties for their own consumption.

Read More

Registered Address

3-A Shivsagar Estate, North Wing Dr A B Road Worli, Mumbai, Maharashtra, 400018

Tel : 91-22-6622 7575
Email : anuh:sk1932.com
Website : http://www.anuhpharma.com

Registrar

Bigshare Services Pvt Ltd

AGM Date (Month) : Aug
Face Value Equity Shares : 5
Market Lot Equity Shares : 1
BSE Code : 506260
NSE Code :
Book Closure Date (Month) : Aug
BSE Group : X
ISIN : INE489G01022

ICICIdirect Anuh Pharma Ltd FAQ

You can buy Anuh Pharma Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Anuh Pharma Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of May 19, 2022 04:01 PM the closing price of Anuh Pharma Ltd was ₹ 97.00.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of May 19, 2022 04:01 PM, the market cap of Anuh Pharma Ltd stood at ₹ 486.09.
The latest PE ratio of Anuh Pharma Ltd as of May 19, 2022 04:01 PM is 16.21
The latest PB ratio of Anuh Pharma Ltd as of May 19, 2022 04:01 PM is 0.43
The 52-week high of Anuh Pharma Ltd is ₹ 156.00 while the 52-week low is ₹ 84.60 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote

CLOSE